AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2008
May 19, 2008
34152_dirs_2008-05-19_1c7f7ccc-c075-411b-ad96-8b82cf02f76e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TARGETED GENETICS CORP /WA/ (TGEN)
CIK: 0000921114
Period of Report: 2008-05-15
Reporting Person: COOK JEREMY CURNOCK (Director, Chairman of the Board)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-05-15 | Common Stock | A | 15000 | $0.00 | Acquired | 30000 | Direct |
Footnotes
F1: These shares represent a grant of restricted stock units that vest 100% on May 15, 2009, the vesting of which shall accelerate upon a change of control, so long as the reporting person is providing services to the issuer on such date.
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Board/Management Information
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23